Importantly, qRT-PCR and immunofluorescence analyses also revealed that double treatment, with both a-Egfl6 and a-PD-L1, reduced tumor expression levels of both IL-10 and Cxcl2 (Figure 6, A and B). Here, EGFL6 is linked to neoplasm.